NEWSTRIKE BRANDS WKN: A2JRPQ ISIN: CA65250J1084 Kürzel: 0N8 Forum: Aktien Thema: Hauptdiskussion
Kommentare 412
opetin_,
02.04.2018 16:15 Uhr
0
TORONTO, 2. April 2018 - Newstrike Resources Ltd. (TSX-V: HIP) ("Newstrike" oder das "Unternehmen") freut sich bekannt zu geben, dass seine hundertprozentige Tochtergesellschaft und lizenzierter Hersteller von Cannabis, Up Cannabis Inc. ("Up Cannabis"), hat eine Herstellerlizenz für die Kultivierung ("Licence") des 160.000 Quadratfuß großen automatisierten Gewächshausstandortes in der Region Niagara ("Niagara Facility") erhalten. Die Lizenz hat eine Laufzeit von drei Jahren und erlaubt die Produktion von Cannabis in der Niagara-Einrichtung von:
Getrocknetes und frisches Marihuana;
Marihuana Pflanzen und Samen;
Cannabis in seiner natürlichen Form: Cannabis Resin; und,
Cannabisöl (abgefüllt).
a
alex1.1001,
19.03.2018 8:12 Uhr
0
Die kurve zeigt eindeutig nach oben
Bin sehr gespannt wie schnell wir wieder die 1€ sehen
opetin_,
14.03.2018 15:17 Uhr
0
40 Cent... den würde ich auch gerne behalten
a
alex1.1001,
14.03.2018 15:08 Uhr
0
Abwarten... wie hoch ist dein Ek?
opetin_,
13.03.2018 12:32 Uhr
0
Oh man das echt ne Durststrecke...
hoffe bald passiert mal wieder was
a
alex1.1001,
22.02.2018 15:19 Uhr
0
Gute news. Mal schaun wie canada reagiert
a
alex1.1001,
22.02.2018 15:18 Uhr
0
TORONTO, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Newstrike Resources Ltd. (TSXV:HIP) (“Newstrike” or the “Company”) is pleased to announce that the previously announced over-allotment option permitting the underwriters to acquire an additional 9,091,500 Units at $1.32 per Unit (the “Over-Allotment Option”) has been exercised in full, providing Newstrike with additional gross proceeds of $12,000,780. The Over-Allotment Option was issued in conjunction with the Company’s previously announced short form prospectus offering of 60,610,000 units (“Units”) at $1.32 per Unit (the “Offering”) which closed on February 16, 2018. The exercise of the Over-Allotment Option increases the total gross proceeds of the Offering to $92,005,980. All Units were sold pursuant to an underwriting agreement with a syndicate of underwriters co-led by INFOR Financial Inc. and Cormark Securities Inc. and including Eight Capital and Haywood Securities Inc.
Each Unit is comprised of one common share of the Company (a “Common Share”) and one common share purchase warrant (a “Warrant”). Each Warrant shall entitle the holder thereof to purchase one additional Common Share at an exercise price of $1.75 until February 16, 2020. In the event that the volume weighted average trading price of the Common Shares for ten (10) consecutive trading days exceeds $2.60, the Company shall have the right, subject to the approval of the TSX Venture Exchange (the “TSXV”), to accelerate the expiry date of the Warrants upon not less than fifteen (15) trading days’ notice. The Company has applied to list the Warrants for trading on the TSXV.
As part of the Over-Allotment Option, the underwriters also received an aggregate of 545,490 compensation options. Each compensation option entitles the holder thereof to acquire one Unit at $1.32 per Unit until February 16, 2020.
Update on Licensing of Niagara Facility
Newstrike’s wholly-owned subsidiary, UP Cannabis Inc. (“Up” or “Up Cannabis”), a licensed producer under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), has been informed by Health Canada’s Office of Medical Cannabis that it has completed the paper-based review of Up’s application for licensing of the first phase of its Niagara Facility, Up’s principal cultivation and production facility, located in Ontario’s Niagara Region. With the documentary review completed, the licensing process for the Niagara Facility now advances to verification by Health Canada of the functionality, physical and security-related compliance of this recently retrofitted 200,000 s.f. facility, of which approximately 160,000 s.f. is dedicated to production. Up believes that this next step will proceed as scheduled and production at the Niagara Facility will commence in the Summer of 2018, with construction of additional manufacturing, packaging and administrative facilities expected to be completed in the fourth quarter of 2018. Further expansion of the Niagara Facility is already underway which, upon completion of all construction and receipt of all requisite regulatory and operational approvals, is expected to double the initial projected annual capacity from approximately 12,500 kg to a projected annual total of approximately 25,000 kg.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended (the “1933 Act”), and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act, as amended, and applicable state securities laws.
Lux311,
21.02.2018 15:05 Uhr
0
Mein Sorgenkind...
a
alex1.1001,
16.02.2018 16:10 Uhr
0
Gute nachrichten. Sollte bald wieder ein stück nach oben gehen
opetin_,
16.02.2018 15:36 Uhr
0
Newstrike Completes Previously Announced $80 Million Bought Deal Financing
TORONTO, ONTARIO – February 16, 2018 – Newstrike Resources Ltd. (TSXV:HIP) (“Newstrike” or the “Company”) is pleased to announce that it has closed its previously announced short form prospectus offering on a bought deal basis. A total of 60,610,000 units of the Company (“Units”) were sold at a price of $1.32 per Unit (the “Issue Price”), for aggregate gross proceeds of $80,005,200 (the “Offering”). The Offering was underwritten by a syndicate of underwriters co-led by INFOR Financial Inc. and Cormark Securities Inc. and including Eight Capital and Haywood Securities Inc. (collectively, the “Underwriters”).
“This transformational Offering provides Newstrike and our wholly-owned licensed producer, Up Cannabis, with the capital required to complete our Niagara Facility, accelerate and enhance the national launch of the Up-Cannabis brand and seize select strategic opportunities that complement our growth strategy”, said Jay Wilgar, Newstrike’s CEO.
In addition, as previously announced, the Company has granted the Underwriters an over-allotment option to purchase up to an additional 15% of the Units at the Issue Price, exercisable in whole or in part, at any time on or prior to the date that is 30 days following the closing of the Offering. If this option is exercised in full, an additional $12,000,780 will be raised pursuant to the Offering and the aggregate proceeds of the Offering will be $92,005,980.
Each Unit is comprised of one common share of the Company (a “Common Share”) and one common share purchase warrant (a “Warrant”). Each Warrant shall entitle the holder thereof to purchase one additional Common Share at an exercise price of $1.75, for a period of 24 months following the closing of the Offering. In the event that the volume weighted average trading price of the Common Shares for ten (10) consecutive trading days exceeds $2.60, the Company shall have the right, subject to the approval of the TSX Venture Exchange (the “TSXV”), to accelerate the expiry date of the Warrants upon not less than fifteen (15) trading days’ notice. The Company has applied to list the Warrants for trading on the TSXV.
“The endorsement of INFOR Financial, Cormark Securities, Eight Capital and Haywood Securities is a tremendous complement to our already-strong shareholder-base and an important demonstration of confidence from the capital markets”, noted Scott Kelly, Newstrike’s Executive Chair. ”We are grateful for the assistance and guidance of our legal team at Cassels Brock & Blackwell LLP and our auditors, DMCL LLP as well as the long-term support of PowerOne Capital, Primary Capital and CRM Global Capital.”
The Company intends to use the proceeds of the Offering to build-out its production facilities, for the retirement of certain debt obligations and for general, corporate and select strategic purposes.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended (the “1933 Act”), and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act, as amended, and applicable state securities laws.
a
alex1.1001,
02.02.2018 7:08 Uhr
0
Ich betrachte newstrike eigentlich auf lange sicht. Bin gespannt was die zukunft bringen wird jedoch glaube ich dass das jahr 2018 sehr erfolgreich wird
MYMaerta,
31.01.2018 14:12 Uhr
0
Ich glaub als Entschädigung
D
DomDomp,
26.01.2018 15:24 Uhr
0
Wofür hat Newstrike die 14 Mios erhalten? Für den geplatzten Deal oder ist das nur eine Rückzahlung?
F
Frankoforte,
24.01.2018 23:12 Uhr
0
Ich bin froh, dass dieser Übernahmezirkus vorbei ist. Das Stornogeld von Cannimed jetzt sinnvoll einsetzen und dann: Neues Spiel, neues Glück!
T
Torvic,
24.01.2018 19:17 Uhr
0
Minus 13 Prozent
a
alex1.1001,
24.01.2018 19:09 Uhr
0
@torvic
Was ist daran so lustig??
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | Nio für normale Kommunikation | ±0,00 % | |
2 | TESLA MOTORS Hauptdiskussion | +0,28 % | |
3 | ATOS Hauptdiskussion | ±0,00 % | |
4 | MicroStrategy | ±0,00 % | |
5 | für alle, die es ehrlich meinen beim Traden. | ||
6 | BTC/USD Hauptdiskussion | -1,11 % | |
7 | Novo Nordisk nach Split | ±0,00 % | |
8 | Canopy Hauptforum | ±0,00 % | |
9 | BAYER Hauptdiskussion | ±0,00 % | |
10 | BORUSSIA DORTMUND Hauptdiskussion | ±0,00 % | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | Nio für normale Kommunikation | ±0,00 % | |
2 | TESLA MOTORS Hauptdiskussion | +0,28 % | |
3 | ATOS Hauptdiskussion | ±0,00 % | |
4 | MicroStrategy | ±0,00 % | |
5 | Canopy Hauptforum | ±0,00 % | |
6 | BAYER Hauptdiskussion | ±0,00 % | |
7 | Novo Nordisk nach Split | ±0,00 % | |
8 | Palantir | +0,85 % | |
9 | MICROSTRATEGY Hauptdiskussion | ±0,00 % | |
10 | BORUSSIA DORTMUND Hauptdiskussion | ±0,00 % | Alle Diskussionen |